Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Cisplatin vs Paclitaxel for Triple Negative Breast Cancer [Phase 2]
A Phase 2 trial comparing cisplatin versus paclitaxel for triple-negative breast cancer has completed, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases [Phase 1]
Phase 1 trial evaluating talimogene laherparepvec in combination with atezolizumab for metastatic triple-negative breast cancer and metastat…
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II Study [Phase 2]
Phase II trial evaluating tislelizumab in combination with eribulin for metastatic, heavily-treated triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel with reparixin vs placebo in metastatic triple-negative breast cancer; study completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer [Phase 3]
Phase 3 trial investigating atezolizumab with chemotherapy vs placebo with chemotherapy in neoadjuvant treatment for early-stage triple-nega…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Establishing the Recommended Biological Dose for AE37 Peptide Vaccine in Combination With Pembrolizumab That Will Enhance the Tumor-specific Immune Response and Demonstrate Efficacy in Patients With Advanced Triple-negative Breast Cancer [Phase 2]
Phase 2 trial update aiming to establish the recommended biological dose for AE37 peptide vaccine with pembrolizumab in advanced triple-nega…
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) [Phase 2, Phase 3]
Study evaluating camrelizumab plus chemotherapy as neoadjuvant therapy for triple negative breast cancer across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: S 81694 Plus Paclitaxel in Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update for S 81694 combined with Paclitaxel in metastatic breast cancer and metastatic triple-negative breast cancer, complet…
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer. [EARLY_Phase 1]
A Phase 1 trial evaluating pembrolizumab (Keytruda) effects on biomarkers in early breast cancer, including triple-negative and hormone rece…
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130) [Phase 3]
Phase 3 trial evaluating atezolizumab plus nab-paclitaxel vs placebo with nab-paclitaxel in previously untreated metastatic triple-negative …
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC) [Phase 3]
Phase 3 trial of sacituzumab govitecan in refractory/relapsed metastatic triple-negative breast cancer has completed; results posted in 2021…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial comparing two platinum regimens in triple-negative breast cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC [Phase 2]
Phase 2 neoadjuvant trial evaluating pembrolizumab with nab-paclitaxel followed by pembrolizumab with epirubicin/cyclophosphamide in triple-…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer [Phase 1, Phase 2]
Phase 1/2 study of sacituzumab govitecan-hziy (IMMU-132) in adults with epithelial cancers; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: PD-1 Inhibitor Concurrent With Chemotherapy as Neoadjuvant Therapy for TNBC [Phase 2]
A Phase 2 trial update investigates a PD-1 inhibitor given concurrently with chemotherapy as neoadjuvant therapy for triple-negative breast …
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 clinical trial update on bevacizumab for metastatic triple negative breast cancer; evaluates efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Talazoparib Maintenance Therapy in Triple-negative Breast Cancer [Phase 2]
Phase 2 clinical trial update for talazoparib maintenance therapy in triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast Cancer [Phase 2]
Phase 2 trial update evaluating MEDI4736 (durvalumab) added to taxane-anthracycline chemotherapy for triple-negative breast cancer has compl…
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: A Study of HX008 for the Treatment of Patients With Metastatic Triple Negative Breast Cancer [Phase 1, Phase 2]
Clinical trial update for HX008 in metastatic triple-negative breast cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer [Phase 2, Phase 3]
A comparative phase 2/3 trial evaluating docetaxel plus carboplatin versus epirubicin plus cyclophosphamide followed by docetaxel as adjuvan…
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast Cancer [Phase 3]
Phase 3 trial of bicalutamide in AR-positive metastatic triple-negative breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating ABT-888 plus carboplatin versus carboplatin with standard chemotherapy versus standard chemotherapy in early-stage …
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial assessing concurrent adjuvant carboplatin with accelerated radiotherapy in triple negative breast cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2021-01-07Clinical Trial Update: A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) [Phase 3]
Phase 3 trial evaluating atezolizumab plus paclitaxel versus placebo plus paclitaxel in untreated locally advanced or metastatic triple-nega…
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC) [Phase 2]
Phase 2 neoadjuvant study evaluating camrelizumab with chemotherapy in triple-negative breast cancer; current status unknown.